stockrowAlzamend Neuro, Inc. (ALZN) vs Ensysce Biosciences, Inc. (ENSC)
- Alzamend Neuro, Inc. ALZN 1.43 −7.74%
- Ensysce Biosciences, Inc. ENSC 0.34 −5.56%
Alzamend Neuro, Inc. and Ensysce Biosciences, Inc. are both Biotechnology companies. Alzamend Neuro, Inc. and Ensysce Biosciences, Inc. are of similar size ($7.5M and $7.0M). Alzamend Neuro, Inc. has the higher net margin (0.00% vs −280.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Alzamend Neuro, Inc. leads on 10 and Ensysce Biosciences, Inc. on 1.
Valuation
Profitability
| Metric | ALZN | ENSC | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (281.32%) | 0.00% |
| Net margin | 0.00% | (280.49%) | 0.00% |
| Free cash flow margin | 0.00% | (196.76%) | 0.00% |
| Return on equity | (163.23%) | (1,295.01%) | (50.12%) |
| Return on assets | (122.36%) | (295.92%) | (45.60%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack